Patient Group Disclosures | Takeda Pharmaceuticals
Patient Group Disclosures
Patient Groups – or patient advocacy groups and patient organizations – are important partners for Takeda. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community. We support patient organizations in our therapeutic areas through sponsorships, grants and donations. In keeping with our commitment to ensure responsible business practices, Takeda believes transparency in our funding decisions is vital to building and maintaining trust with our stakeholders.
**Takeda**
* [Reports 2025](https://assets-dam.takeda.com/image/upload/v1782407093/Global/Patient_Group_Disclosures/Argentina/Argentina_Patient_Organisation_report_2025.pdf)
* [Reports 2024](https://assets-dam.takeda.com/image/upload/v1749835762/Global/Patient_Group_Disclosures/Argentina/Argentina_Pat_Org_report_2024.pdf)
* [Reports 2023](https://assets-dam.takeda.com/image/upload/v1717689083/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Argentina_PO_Report_2023.pdf)
* [Reports](https://medicinesaustralia.com.au/code-of-conduct/transparency-reporting/health-consumer-organisation-support-reports/member-company-reports/)
* [Reports](https://www.takeda.com/de-at/who-we-are/company-information/zusammenarbeit-mit-patientenorganisationen/)
* [Reports](https://www.betransparent.be/en/)
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1782754696/Global/Patient_Group_Disclosures/Bosnia_and_Herzegovina/2025/Bosnia_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782754699/Global/Patient_Group_Disclosures/Bosnia_and_Herzegovina/2025/Bosnia_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750979906/Global/Patient_Group_Disclosures/Bosnia_and_Herzegovina/2024/Bosnia_and_Herzegovina_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750979902/Global/Patient_Group_Disclosures/Bosnia_and_Herzegovina/2024/BA_PO_Methodology_Note_Bosnian_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719394603/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Bosnia_Herzegovina_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1720075867/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Bosnia_Herzegovina_PO_Methodology_Note_2023_Bosnian.pdf)
**Takeda**
**2025**
* [Reports (EUR)](https://assets-dam.takeda.com/image/upload/v1782754333/Global/Patient_Group_Disclosures/Bulgaria/Bulgaria_PO_report_2025_EUR.pdf)
* [Reports (BGN)](https://assets-dam.takeda.com/image/upload/v1782754333/Global/Patient_Group_Disclosures/Bulgaria/Bulgaria_PO_report_2025_BGN.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782754340/Global/Patient_Group_Disclosures/Bulgaria/Bulgaria_EFPIA_Methodology_Note_2025_1.pdf)
**2024**
* [Reports](https://assets-dam.takeda.com/image/upload/v1750979582/Global/Patient_Group_Disclosures/Bulgaria/Bulgaria_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750979579/Global/Patient_Group_Disclosures/Bulgaria/Bulgaria_PO_Methodology_Note_2024.pdf)
**2023**
* [Reports](https://assets-dam.takeda.com/image/upload/v1719233059/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Bulgaria_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719233063/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Bulgaria_PO_Methodology_Notes_2023_Bulgarian.pdf)
**Takeda**
* ****[Reports 2025](https://assets-dam.takeda.com/image/upload/v1782406512/Global/Patient_Group_Disclosures/Colombia/Colombia_Patient_Organisation_Report_2025.pdf)
* ****[Reports 2024](https://assets-dam.takeda.com/image/upload/v1749731229/Global/Patient_Group_Disclosures/Colombia/Colombia_Pat_org_Report_2024.pdf)
* ****[Reports 2023](https://assets-dam.takeda.com/image/upload/v1717689046/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Colombia_PO_Report_2023.pdf)
**Takeda**
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1782757236/Global/Patient_Group_Disclosures/Croatia/Croatia_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782757237/Global/Patient_Group_Disclosures/Croatia/Croatia_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750984062/Global/Patient_Group_Disclosures/Croatia/Croatia_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750984059/Global/Patient_Group_Disclosures/Croatia/Croatia_PO_Methodology_Note_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719396224/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Croatia_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1720075865/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Croatia_PO_Methodology_Note_Croatian.pdf)
* [**Reports**](https://www.takeda.com/cs-cz/odpovednost/socialni-odpovdnost-v-eske-republice/)
* [Reports](https://www.enli.dk/samarbejder-med-patientforeninger)
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1780063670/Global/Patient_Group_Disclosures/Estonia/Estonia_Patient_org_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1780063675/Global/Patient_Group_Disclosures/Estonia/Estonia_Takeda_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1748619107/Global/Patient_Group_Disclosures/Estonia/Estonia_Patient_orgnisation_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1748619135/Global/Patient_Group_Disclosures/Estonia/Estonia_Takeda_PO_Methodology_Note_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719401843/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Estonia_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719401849/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Estonia_PO_Methodology_Note_2023_Estonian.pdf)
* [Reports](https://www.takeda.com/fi-fi/vastuullisuus/tuemme/)
* [Reports](https://www.transparence.sante.gouv.fr/)
* [Reports](https://www.takeda.com/de-de/unternehmerische-verantwortung/transparenz/)
Takeda
**Takeda**
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1782756767/Global/Patient_Group_Disclosures/Hungary/Hungary_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782756769/Global/Patient_Group_Disclosures/Hungary/Hungary_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750983777/Global/Patient_Group_Disclosures/Hungary/Hungary_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750983788/Global/Patient_Group_Disclosures/Hungary/Hungary_PO_Methodology_Note_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719396712/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Hungary_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719396715/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Hungary_PO_Methodology_Notes_2023_Hungarian.pdf)
* [Reports](https://vistor.is/um-vistor/birting-upplysinga/)
* [Reports](https://www.takeda.com/en-ie/corporate-responsibility/transparency/patient-group-disclosures/)
* [**Reports**](https://www.takeda.com/it-it/le-nostre-storie/associazioni-di-pazienti/)
**Takeda**
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1780323564/Global/Patient_Group_Disclosures/Latvia/2025/Latvia_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1780323568/Global/Patient_Group_Disclosures/Latvia/2025/Latvia_PO_Methodology_Note_Latvian_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750769831/Global/Patient_Group_Disclosures/Latvia/2024/Latvia_PO_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750769831/Global/Patient_Group_Disclosures/Latvia/2024/Latvia_PO_Methodology_Note_Latvian_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719400869/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Latvia_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719400869/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Latvia_PO_Methodology_Notes_2023_Latvian.pdf)
**Takeda**
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1782757501/Global/Patient_Group_Disclosures/Lithuania/2025/Lithuania_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782757502/Global/Patient_Group_Disclosures/Lithuania/2025/Lithuania_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750443520/Global/Patient_Group_Disclosures/Lithuania/2024/Lithuania_PO_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750443525/Global/Patient_Group_Disclosures/Lithuania/2024/Lithuania_PO_Methodology_Note_Lithuanian.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719396891/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Lithuania_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719396897/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Lithuania_PO_Methodology_Notes_2023_Lithuanian.pdf)
* ****[**Reports**](https://www.takeda.com/en-be/corporate-responsibility/transparency/)
**Takeda**
* [Reports 2025](https://assets-dam.takeda.com/image/upload/v1783346090/Global/Patient_Group_Disclosures/Mexico/Mexico_PO_disclosure_template_2025.pdf)
* [Reports 2024](https://assets-dam.takeda.com/image/upload/v1750336344/Global/Patient_Group_Disclosures/Mexico/Mexico_Patient_Group_Disclosures_2024.pdf)
* [Reports 2023](https://assets-dam.takeda.com/image/upload/v1718092076/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Mexico_PO_Report_2023.pdf)
* [**Reports**](http://www.transparantieregister.nl/home)
2025
- No Transfers of Value (ToV) were made to Patient Organizations during the 2025 reporting year.
2024
2023
* [Reports](https://www.takeda.com/nn-no/Samfunnsansvar/samfunnsansvar/pasientorganisasjoner/)
**Takeda**
**2025**
* [Reports (English)](https://assets-dam.takeda.com/image/upload/v1782753027/Global/Patient_Group_Disclosures/Poland/Poland_Po_Report_2025_English.pdf)
* [Reports (Polish)](https://assets-dam.takeda.com/image/upload/v1782753029/Global/Patient_Group_Disclosures/Poland/Poland_Po_Report_2025_Polish.pdf)
* [Methodology (English)](https://assets-dam.takeda.com/image/upload/v1782753029/Global/Patient_Group_Disclosures/Poland/Poland_PO_Methodology_Note_2025_English.pdf)
* [Methodology (Polish)](https://assets-dam.takeda.com/image/upload/v1782753029/Global/Patient_Group_Disclosures/Poland/Poland_PO_Methodology_Note_2025_Polish.pdf)
**2024**
* [Reports](https://assets-dam.takeda.com/image/upload/v1750786280/Global/Patient_Group_Disclosures/Poland/Poland_PO_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750786283/Global/Patient_Group_Disclosures/Poland/Poland_PO_Methodology_Note_Polish_2024.pdf)
**2023**
* [Reports](https://assets-dam.takeda.com/image/upload/v1719397155/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Poland_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719397159/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Poland_PO_Methodology_Notes_2023_Polish.pdf)
* [**Reports**](https://www.takeda.com/pt-pt/responsabilidade-social-corporativa/apoios-conferidos-a-associacoes-de-doentes/)
Transfer of values to Patient Organizations are included in the Disclosure Report.
Transfer of values to Patient Organizations are included in the Disclosure Report.* [**Reports**](https://www.takeda.com/ru-ru/who-we-are/information/)
**Takeda**
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1782758105/Global/Patient_Group_Disclosures/Serbia/Serbia_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782758106/Global/Patient_Group_Disclosures/Serbia/Serbia_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750978911/Global/Patient_Group_Disclosures/Serbia/Serbia_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750978910/Global/Patient_Group_Disclosures/Serbia/Serbia_PO_Methodology_Note_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719401075/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Serbia_PO_Report_2023_English.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719401079/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Serbia_PO_Methodology_Notes_2023_Serbian.pdf)
* [**Reports**](https://www.takeda.com/sk-sk/zodpovednost/)
**Takeda**
**2025**
* [Report](https://assets-dam.takeda.com/image/upload/v1782753569/Global/Patient_Group_Disclosures/Slovenia/2025/Slovenia_PO_report_2025.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1782753573/Global/Patient_Group_Disclosures/Slovenia/2025/Slovenia_PO_Methodology_Note_2025.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1750972452/Global/Patient_Group_Disclosures/Slovenia/2024/Slovenia_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1750972462/Global/Patient_Group_Disclosures/Slovenia/2024/Slovenia_PO_Methodology_Note_2024.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719393619/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Slovenia_PO_Report_2023_Slovenian.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1720075866/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Slovenia_PO_Methodology_Note_2023_Slovenian.pdf)
* [Reports](https://www.takeda.com/es-es/transparencia/colaboracion-con-asociaciones-de-pacientes/)
* [Reports](https://www.takeda.com/sv-se/etik-och-transparens/)
* [**Reports**](https://www.takeda.com/de-ch/unternehmerische-verantwortung/transparenz/patientenorganisationen/)
**Takeda**
* [Reports 2025](https://assets-dam.takeda.com/image/upload/v1777997615/Global/Patient_Group_Disclosures/Turkiye/Turkiye_Pat_Org_report_2025.pdf)
* [Reports 2024](https://assets-dam.takeda.com/image/upload/v1741108406/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2024/2024_Reports_Turkiye.pdf)
* [Reports 2023](https://assets-dam.takeda.com/image/upload/v1714504053/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/2023_Reports_Turkiye.pdf)
**2024**
* [Report](https://assets-dam.takeda.com/image/upload/v1751290395/Global/Patient_Group_Disclosures/Ukraine/2024/Ukraine_Patient_organization_Report_2024.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1751290398/Global/Patient_Group_Disclosures/Ukraine/2024/Ukraine_PO_Methodology_Note_2024__English.pdf)
**2023**
* [Report](https://assets-dam.takeda.com/image/upload/v1719576504/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Ukraine_PO_report_2023.pdf)
* [Methodology](https://assets-dam.takeda.com/image/upload/v1719576509/legacy-dotcom/siteassets/system/who-we-are/values-and-corporate-governance/transparency-disclosures/patient-group-disclosures/2023/Ukraine_PO_Methodology_Note_English.pdf)
* ****[**Reports**](https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/)****